BioSpace News Archive

Emerging Era Of CAR T Cell Therapies Market

Kuick Research Report Gives Insight On 600 CAR T Cell Therapies In Clinical Trials.

June 9, 2022
·
4 min read
Pharm Country

UPDATE: Eyenovia Announces Virtual 2022 Annual Meeting of Stockholders

Eyenovia, Inc. announced that its Annual Meeting of Stockholders will be held virtually via live webcast on Thursday, June 16, 2022 at 10:00 am EDT.

June 9, 2022
·
1 min read
Drug Development

Panavance Therapeutics Announces Publication of Encouraging Preclinical Data Evaluating GP-2250 for the Treatment of Pancreatic Neuroendocrine Carcinoma

Panavance Therapeutics Inc. (“Panavance” or the “Company”), a clinical-stage pharmaceutical company advancing the development of a novel oncology therapeutic designed to disrupt cancer’s energy metabolism and improve quality of life for patients, today announced the publication of positive data from a preclinical study evaluating GP-2250 for the treatment of pancreatic neuroendocrine carcinoma.

June 9, 2022
·
6 min read
Biodefense Market Demand 2022-2030: Increasing Investment from Pharmaceutical Companies to Develop Vaccines to Prevent Bio Threats Is Expected to Drive Industry Revenue Growth

The global biodefense market size is expected to reach USD 32.80 Billion in 2030 and register a revenue CAGR of 8.7% over the forecast period, according to latest report by Reports and Data.

June 9, 2022
·
7 min read
Colchicine Market Growth 2022-2030: Increasing Clinical Studies of Colchicine Drugs for Various Applications

The global colchicine market size is expected to reach USD 2,552.84 Million in 2030 and register a revenue CAGR of 8.4%, according to the latest report by Reports and Data.

June 9, 2022
·
6 min read
Live Cell Imaging Market 2022-2030: Rapid Advancements in Live Cell Imaging Technology, Government Initiatives to Promote Stem Cell Research

The global live cell imaging market is expected to reach USD 4.26 billion in 2030 and register a revenue CAGR of 8.7% during the forecast period, according to latest report published by Reports and Data.

June 9, 2022
·
6 min read
Pharm Country

Tiziana Life Sciences PLC (TLSA: NASDAQ) Releases Research Report: Clinical Improvements for 2nd SPMS Patient

Tiziana Life Sciences PLC announced positive clinical results for its second secondary progressive multiple sclerosis patient in a June 8th press release.

June 9, 2022
·
9 min read
Policy

Landmark Publication Further Validates Approach to Expand the Potential Universe of Cancer-specific Targets by Probing the “Grey Genome”

Mnemo Therapeutics announced a publication in Cell Reports that demonstrates peptides derived from transposable elements – mobile regions of DNA that move to other areas of the genome – may represent cancer-specific targets for immunotherapy.

June 9, 2022
·
4 min read
BioCapital

NEXT Molecular Analytics Receives Accreditation from the New York State Department of Health for its L-Asparaginase Enzyme Activity Assay Platform

NEXT Bio Research Services LLC, dba NEXT Molecular Analytics is pleased to announce that the New York State Department of Health has accredited the Company’s L-Asparaginase enzyme activity assay platform.

June 9, 2022
·
2 min read
Business

IRLAB Strengthens Its Management Team by Appointing Richard Godfrey as New CEO and Nicholas Waters as Executive Vice President and Head of R&D

IRLAB Therapeutics IRLAB announced that additional expertise is added to the company’s management team to leverage opportunities arising from recent commercial and scientific successes.

June 9, 2022
·
4 min read